VJHemOnc Podcast

Medical

The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare...

Episodes

Using BTK inhibitors in lymphoma: practical considerations for community physicians

AAV gene therapy in hemophilia: progress, challenges and what comes next

Clinical considerations in MCL management: frailty assessment, the multidisciplinary team & managing the use of BTKis

Sequencing therapies in multiple myeloma: navigating an expanding treatment landscape

The evolving treatment landscape in ALL: the growing role of immunotherapy and reduced reliance on chemotherapy

Precision medicine in MDS: tailoring treatment through molecular profiling

The current and future role of BTK inhibitors across non-Hodgkin lymphoma subtypes

The diagnosis and management of hematologic malignancies during pregnancy

Hodgkin lymphoma in 2026: frontline strategies, ctDNA, and treatment after relapse

Sequencing BTK inhibitor therapy in CLL: treatment considerations and emerging strategies

Precision medicine in AML: from targeted therapy to transplantation

MPNs in focus: disease progression, risk assessment, and emerging treatments

The evolving role of cellular therapies and T-cell engagers in lymphoma

Multiple myeloma in 2026: MRD, BCMA therapies, CAR-T, and the path to cure

Dual-targeting CAR T-cell therapies in LBCL: efficacy, safety, and bridging therapy

Advances in gene-based therapies for SCD and thalassemia: access, outcomes & innovation

The evolving role of BTK inhibitors in CLL

Adverse events in the post-CAR T-cell therapy setting: infections, less common toxicities, and advice for physicians

The evolving treatment landscape in MCL: chemo-free strategies, BTK inhibitors, and changing standards of care

Advances in stem cell transplantation from EBMT 2026: managing GvHD, donor selection & evolving clinical strategies